Literature DB >> 12893762

High-dose therapy in multiple myeloma.

Joan Bladé1, David H Vesole.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12893762     DOI： 10.1182/blood-2003-01-0073

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  16 in total

Review 1.  Multiple myeloma.

Authors:  S Vincent Rajkumar
Journal:  Curr Probl Cancer       Date:  2009 Jan-Feb       Impact factor: 3.187

2.  Multiple myeloma: 2018 update on diagnosis, risk‐stratification, and management

Authors: 
Journal:  Am J Hematol       Date:  2018-08-16       Impact factor: 10.047

3.  Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients.

Authors:  Maria Teresa Cibeira; Vaishali Sanchorawala; David C Seldin; Karen Quillen; John L Berk; Laura M Dember; Adam Segal; Frederick Ruberg; Hans Meier-Ewert; Nancy T Andrea; J Mark Sloan; Kathleen T Finn; Gheorghe Doros; Joan Blade; Martha Skinner
Journal:  Blood       Date:  2011-08-09       Impact factor: 22.113

4.  Benefit from autologous stem cell transplantation in primary refractory myeloma? Different outcomes in progressive versus stable disease.

Authors:  Laura Rosiñol; Ramón García-Sanz; Juan José Lahuerta; Miguel Hernández-García; Miquel Granell; Javier de la Rubia; Albert Oriol; Belén Hernández-Ruiz; Consuelo Rayón; Isabel Navarro; Juan Carlos García-Ruiz; Joan Besalduch; Santiago Gardella; Javier López Jiménez; Joaquín Díaz-Mediavilla; Adrián Alegre; Jesús San Miguel; Joan Bladé
Journal:  Haematologica       Date:  2011-11-04       Impact factor: 9.941

5.  Autologous stem cell transplantation in myeloma: the St James's Hospital experience, 1997-2003.

Authors:  P J Hayden; A O'Driscoll; N Gardiner; R Swords; J Sargent; F Ni Ainle; A Fortune; P T Murphy; M Leahy; F Jackson; M Ryan; B Hennessy; M Cahill; G M Crotty; H Enright; E Conneally; E Vandenberghe; S R McCann; P V Browne
Journal:  Ir J Med Sci       Date:  2005 Apr-Jun       Impact factor: 1.568

6.  Multiple myeloma: 2012 update on diagnosis, risk-stratification, and management.

Authors:  S Vincent Rajkumar
Journal:  Am J Hematol       Date:  2012-01       Impact factor: 10.047

7.  Generation of antitumor invariant natural killer T cell lines in multiple myeloma and promotion of their functions via lenalidomide: a strategy for immunotherapy.

Authors:  Weihua Song; Hans J J van der Vliet; Yu-Tzu Tai; Rao Prabhala; Ruojie Wang; Klaus Podar; Laurence Catley; Masood A Shammas; Kenneth C Anderson; Steven P Balk; Mark A Exley; Nikhil C Munshi
Journal:  Clin Cancer Res       Date:  2008-11-01       Impact factor: 12.531

Review 8.  Treatment of myeloma: cure vs control.

Authors:  S Vincent Rajkumar
Journal:  Mayo Clin Proc       Date:  2008-10       Impact factor: 7.616

9.  Identification of HLA-A2 restricted T-cell epitopes within the conserved region of the immunoglobulin G heavy-chain in patients with multiple myeloma.

Authors:  Sebastian Belle; Fang Han; Maud Condomines; Olaf Christensen; Mathias Witzens-Harig; Bernd Kasper; Christian Kleist; Peter Terness; Marion Moos; Friedrich Cremer; Dirk Hose; Anthony D Ho; Hartmut Goldschmidt; Bernard Klein; Michael Hundemer
Journal:  Eur J Haematol       Date:  2008-03-19       Impact factor: 2.997

Review 10.  Multiple myeloma: 2016 update on diagnosis, risk-stratification, and management.

Authors:  S Vincent Rajkumar
Journal:  Am J Hematol       Date:  2016-07       Impact factor: 10.047
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.